To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ALG3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
335 supporting clones for gene ALG3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_005787.5   .a 1 to 1533 1 to 1533 exact RefSeq, AAA   1533/1533
(100 %)
0 diff
(100 %id)
Y09022 brain .a 1 to 1437 1 to 1437 exact tiling clone, AAA   1437/1437
(100 %)
3 diff
(99.8 %id)
BP192901 brain .a 10 to 593 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CX760732 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 11 to 492 37 to 518     Submitted on the opposite strand 482/518
(93 %)
6 diff
(98.9 %id)
CD101716 Human Placenta, placenta .a 11 to 750 25 to 773       749/778
(96 %)
13 diff
(98.4 %id)
BI907985 leukocyte .a 18 to 964 24 to 966       943/981
(96 %)
50 diff
(95.0 %id)
BM544940 ovary (pool of 3) .a 18 to 889 22 to 907       884/1216
(72 %)
27 diff
(97.8 %id)
TI_57236553   .a 18 to 964 24 to 966   AAA   943/1082
(87 %)
50 diff
(95.4 %id)
CR592328 Neuroblastoma Cot 25-normalized .a 19 to 1477 1 to 1459       1459/1459
(100 %)
0 diff
(100 %id)
BX353984 Neuroblastoma Cot 25-normalized .a 19 to 712 1 to 693   fully sequenced,   693/693
(100 %)
1 diff
(99.9 %id)
CD518015 White Matter .a 20 to 833 29 to 845       817/845
(96 %)
10 diff
(98.9 %id)
BF315927 brain, neuroblastoma .a 21 to 808 1 to 786       786/790
(99 %)
11 diff
(98.7 %id)
BF316822 brain, neuroblastoma .a 21 to 800 1 to 775       775/917
(84 %)
16 diff
(98.3 %id)
BG823228 adenocarcinoma cell line, colon .a 21 to 662 1 to 642       642/644
(99 %)
2 diff
(99.7 %id)
BI195605 brain, neuroblastoma .a 21 to 678 1 to 658       658/658
(100 %)
0 diff
(100 %id)
CD559079 White Matter .a 21 to 758 1 to 743       743/918
(80 %)
9 diff
(99.1 %id)
BM544242 ovary (pool of 3) .a 22 to 878 1 to 862       862/1064
(81 %)
21 diff
(98.1 %id)
CA454319   .a 22 to 471 25 to 472       448/527
(85 %)
14 diff
(97.4 %id)
BP248607 Kidney .a 23 to 605 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CR594345 HeLa cells Cot 25-normalized .a 25 to 1415 1 to 1391       1391/1391
(100 %)
0 diff
(100 %id)
BX400990   .a 25 to 712 1 to 687   fully sequenced,   687/687
(100 %)
1 diff
(99.9 %id)
BG386607 adenocarcinoma cell line, colon .a 25 to 798 1 to 775       775/779
(99 %)
10 diff
(98.8 %id)
BG822610 adenocarcinoma cell line, colon .a 25 to 787 1 to 763       763/763
(100 %)
1 diff
(99.9 %id)
BG824441 adenocarcinoma cell line, colon .a 25 to 891 1 to 865       865/866
(99 %)
8 diff
(99.1 %id)
BC002839 Placenta, choriocarcinoma .a 26 to 1437 1 to 1412   available from MGC, AAA   1412/1412
(100 %)
0 diff
(100 %id)
CR616285 HeLa cells Cot 25-normalized .a 26 to 1396 1 to 1371       1371/1371
(100 %)
0 diff
(100 %id)
CR619480 Placenta Cot 25-normalized .a 26 to 1388 1 to 1363       1363/1363
(100 %)
0 diff
(100 %id)
BX337521 Placenta Cot 25-normalized .a 26 to 667 1 to 641   fully sequenced,   641/641
(100 %)
1 diff
(99.9 %id)
AL555582 placenta .a 26 to 788 1 to 763   fully sequenced,   763/763
(100 %)
0 diff
(100 %id)
BG469226 adenocarcinoma cell line, colon .a 26 to 731 1 to 714       714/714
(100 %)
23 diff
(96.8 %id)
CF272250 Brain glioblastoma .a 26 to 902 1 to 882       882/890
(99 %)
6 diff
(99.4 %id)
TI_1948128223   .a 26 to 711 123 to 814       691/1092
(63 %)
24 diff
(97.9 %id)
TI_1948128558   .a 26 to 758 126 to 856       731/1112
(65 %)
21 diff
(98.2 %id)
TI_1948128897   .a 26 to 597 121 to 698       578/1075
(53 %)
33 diff
(97.0 %id)
TI_1948129221   .a 26 to 577 122 to 675       554/1174
(47 %)
22 diff
(98.2 %id)
TI_1948129222   .a 26 to 700 133 to 809       677/1100
(61 %)
13 diff
(98.9 %id)
BE409583 choriocarcinoma, placenta .a 27 to 826 1 to 795       795/830
(95 %)
14 diff
(98.4 %id)
BM811510 astrocytoma grade IV, cell line, brain .a 27 to 931 1 to 910       910/1047
(86 %)
9 diff
(99.2 %id)
BQ927823 carcinoma, cell line, Prostate .a 27 to 756 1 to 732       732/985
(74 %)
4 diff
(99.6 %id)
BQ958872 carcinoma, cell line, Prostate .a 27 to 877 1 to 858       858/986
(87 %)
21 diff
(97.9 %id)
BQ961060 carcinoma, cell line, Prostate .a 27 to 631 1 to 607       607/979
(62 %)
5 diff
(99.5 %id)
BU543381 carcinoma, cell line, Prostate .a 27 to 877 1 to 868       868/934
(92 %)
30 diff
(96.8 %id)
BU543950 carcinoma, cell line, Prostate .a 27 to 823 1 to 801       801/888
(90 %)
6 diff
(99.4 %id)
TI_1948128898   .a 27 to 700 122 to 800       679/1080
(62 %)
27 diff
(97.5 %id)
BE885380 leiomyosarcoma, uterus .a 28 to 634 1 to 608       608/616
(98 %)
3 diff
(99.6 %id)
BQ053899 blood, natural killer cells, cell line .a 28 to 847 1 to 834       832/1107
(75 %)
17 diff
(98.5 %id)
DN995375 breast cancer, Mammary gland (cancer tissue) .a 28 to 604 9 to 585       577/585
(98 %)
11 diff
(98.2 %id)
BU855413 ovary, teratocarcinoma, cell line .a 29 to 754 84 to 817       734/949
(77 %)
30 diff
(96.9 %id)
BU844359 ovary, teratocarcinoma, cell line .a 30 to 633 1 to 611       611/805
(75 %)
8 diff
(99.1 %id)
CV026296 mixed .a 32 to 620 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
BG425232 Kidney, renal cell adenocarcinoma .a 33 to 800 1 to 761       761/783
(97 %)
13 diff
(98.4 %id)
BG750859 eye, normal pigmented retinal epithelium .a 34 to 726 1 to 693       693/694
(99 %)
1 diff
(99.9 %id)
TI_1948128559   .a 34 to 746 141 to 859       719/1048
(68 %)
24 diff
(97.8 %id)
BM480352 eye, retinoblastoma .a 35 to 967 1 to 940       940/1091
(86 %)
16 diff
(98.6 %id)
BI115890 lung, small cell carcinoma .a 36 to 820 1 to 783       783/783
(100 %)
5 diff
(99.4 %id)
BI261339 lymph, lymphoma, cell line .a 36 to 748 1 to 718   fully sequenced,   718/718
(100 %)
8 diff
(98.9 %id)
BU844804 ovary, teratocarcinoma, cell line .a 36 to 859 28 to 862       835/906
(92 %)
20 diff
(97.8 %id)
BC021062 Lymph, Burkitt lymphoma .a 37 to 1437 1 to 1401   available from MGC, AAA   1401/1401
(100 %)
2 diff
(99.9 %id)
BE514429 Burkitt lymphoma, lymph .a 37 to 721 31 to 714       684/714
(95 %)
8 diff
(98.9 %id)
BE562387 Burkitt lymphoma, lymph .a 37 to 904 30 to 891       862/1150
(74 %)
44 diff
(96.2 %id)
BG419203 Kidney, renal cell adenocarcinoma .a 38 to 792 1 to 749       749/1037
(72 %)
13 diff
(98.8 %id)
BQ058110 lymph, lymphoma, cell line .a 38 to 756 1 to 720       720/1056
(68 %)
3 diff
(99.8 %id)
CA488300   .a 40 to 908 1 to 877       877/900
(97 %)
15 diff
(98.4 %id)
CR611890 Placenta Cot 25-normalized .a 41 to 1237 1 to 1197       1197/1197
(100 %)
0 diff
(100 %id)
BX361179 Placenta Cot 25-normalized .a 41 to 815 1 to 773   fully sequenced,   773/773
(100 %)
3 diff
(99.7 %id)
BU528913 epidermoid carcinoma, cell line, lung .a 41 to 601 12 to 573       562/1185
(47 %)
20 diff
(98.4 %id)
BE746096 adenocarcinoma cell line, ovary .a 44 to 665 1 to 622       622/622
(100 %)
3 diff
(99.6 %id)
TI_57217637   .a 44 to 890 28 to 883       856/896
(95 %)
29 diff
(96.8 %id)
CN292750 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 45 to 623 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
CD672690 eye, Iris .a 45 to 673 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BE383257 brain, neuroblastoma .a 46 to 583 1 to 545       545/545
(100 %)
10 diff
(98.2 %id)
BC004313 Brain, neuroblastoma .a 46 to 1526 1 to 1481   tiling clone, available from MGC, AAA   1481/1481
(100 %)
0 diff
(100 %id)
BF980509 duodenal adenocarcinoma, cell line, small intestine .a 46 to 755 11 to 715       705/923
(76 %)
23 diff
(97.6 %id)
BI223346 cervical carcinoma cell line, cervix .a 46 to 942 1 to 894       894/897
(99 %)
18 diff
(98.0 %id)
BQ069417 brain, neuroblastoma, cell line .a 46 to 643 20 to 617       598/1127
(53 %)
18 diff
(98.5 %id)
CR593059 Neuroblastoma Cot 25-normalized .a 47 to 1398 1 to 1352       1352/1352
(100 %)
0 diff
(100 %id)
AL525025 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 47 to 788 1 to 742   fully sequenced,   742/742
(100 %)
2 diff
(99.8 %id)
CA489027   .a 47 to 633 1 to 590       590/890
(66 %)
8 diff
(99.2 %id)
BU176670 eye, retinoblastoma .a 48 to 851 1 to 817       815/866
(94 %)
15 diff
(98.3 %id)
BM557180 melanotic melanoma, skin .a 49 to 967 1 to 939       939/1051
(89 %)
34 diff
(96.8 %id)
BU168856 ductal carcinoma, cell line, Pancreas .a 49 to 751 1 to 705       705/948
(74 %)
9 diff
(99.1 %id)
BI752952 brain .a 52 to 890 1 to 848       848/861
(98 %)
23 diff
(97.4 %id)
BE264913 lung, small cell carcinoma .a 53 to 739 1 to 678       678/679
(99 %)
10 diff
(98.6 %id)
BG740747 skin .a 53 to 946 1 to 894       894/896
(99 %)
12 diff
(98.7 %id)
BE384662 melanotic melanoma, skin .a 54 to 467 1 to 416       416/416
(100 %)
3 diff
(99.3 %id)
BE407300 choriocarcinoma, placenta .a 55 to 477 1 to 423       423/482
(87 %)
0 diff
(100 %id)
BE906118 epithelioid carcinoma, Pancreas .a 56 to 871 1 to 820       820/1132
(72 %)
23 diff
(98.0 %id)
BI856017 breast, mammary adenocarcinoma, cell line .a 56 to 867 1 to 814       814/816
(99 %)
10 diff
(98.8 %id)
TI_57186496   .a 56 to 867 53 to 866       814/816
(99 %)
10 diff
(98.8 %id)
BG335646 choriocarcinoma, placenta .a 57 to 808 1 to 755       755/849
(88 %)
18 diff
(97.9 %id)
BI225028 Burkitt lymphoma, lymph .a 57 to 919 1 to 857       857/860
(99 %)
14 diff
(98.4 %id)
BI225254 Burkitt lymphoma, lymph .a 57 to 759 1 to 703       703/705
(99 %)
3 diff
(99.6 %id)
BE393048 endometrium, adenocarcinoma cell line, uterus .a 64 to 545 1 to 484       484/486
(99 %)
7 diff
(98.6 %id)
BF310175 brain, neuroblastoma .a 64 to 758 1 to 684       684/934
(73 %)
17 diff
(98.2 %id)
CR620598 B cells (Ramos cell line) Cot 25-normalized .a 65 to 1408 1 to 1344       1344/1344
(100 %)
0 diff
(100 %id)
BX364024   .a 65 to 788 1 to 722   fully sequenced,   722/722
(100 %)
2 diff
(99.8 %id)
BE905186 epithelioid carcinoma, Pancreas .a 66 to 808 1 to 739       739/748
(98 %)
12 diff
(98.4 %id)
BE783428 eye, retinoblastoma .a 69 to 792 1 to 725       725/1048
(69 %)
8 diff
(99.3 %id)
BE791811 lung, small cell carcinoma .a 74 to 872 1 to 792       792/972
(81 %)
15 diff
(98.5 %id)
BE273591 Kidney, renal cell adenocarcinoma .a 75 to 674 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BF035317 adenocarcinoma, ovary .a 75 to 759 1 to 684       684/717
(95 %)
3 diff
(99.6 %id)
BE871036 adenocarcinoma, colon .a 76 to 795 1 to 715       715/906
(78 %)
12 diff
(98.7 %id)
CN292751 embryonic stem cells, cell lines H1, H7, andH9 .a 98 to 654 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BF791576 adrenal cortex carcinoma, cell line, adrenal gland .a 108 to 636 1 to 540       540/844
(63 %)
12 diff
(98.6 %id)
BE313598 brain, neuroblastoma .a 138 to 706 1 to 569       569/569
(100 %)
0 diff
(100 %id)
AW880981 ovary .a 190 to 621 1 to 430       430/430
(100 %)
5 diff
(98.9 %id)
AW880971 ovary .a 192 to 588 1 to 397       397/397
(100 %)
3 diff
(99.3 %id)
BX337520 Placenta Cot 25-normalized .a 606 to 1388 780 to 1   fully sequenced,   780/780
(100 %)
11 diff
(98.6 %id)
BX353983 Neuroblastoma Cot 25-normalized .a 682 to 1477 795 to 1   fully sequenced,   795/795
(100 %)
4 diff
(99.5 %id)
BX400989   .a 682 to 1410 736 to 6   fully sequenced,   731/736
(99 %)
1 diff
(99.9 %id)
BI261961 lymph, lymphoma, cell line .a 718 to 1361 644 to 1   fully sequenced,   644/644
(100 %)
0 diff
(100 %id)
AL525024 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 727 to 1398 669 to 1   fully sequenced,   669/669
(100 %)
31 diff
(95.4 %id)
AL578047 placenta .a 727 to 1396 674 to 1   fully sequenced,   670/670
(100 %)
20 diff
(97.1 %id)
BX364023   .a 727 to 1408 685 to 1   fully sequenced,   685/685
(100 %)
6 diff
(99.2 %id)
BX361178 Placenta Cot 25-normalized .a 785 to 1184 462 to 62   fully sequenced,   401/462
(86 %)
1 diff
(99.8 %id)
BI226318 Burkitt lymphoma, lymph .b 1 to 692 1 to 692   tiling clone,   692/694
(99 %)
2 diff
(99.8 %id)
TI_149291557   .b 480 to 1273 848 to 66   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 783/966
(81 %)
13 diff
(98.7 %id)
BM974168 lung .b 610 to 1273 680 to 17   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 664/680
(97 %)
0 diff
(100 %id)
AI313444 lung .b 799 to 1272 474 to 1   tiling clone,   474/474
(100 %)
0 diff
(100 %id)
NR_024534.1   .c 1 to 1496 1 to 1496 exact RefSeq, tiling clone, AAA   1496/1496
(100 %)
0 diff
(100 %id)
TI_57147518   .c 18 to 881 29 to 892       864/959
(90 %)
35 diff
(96.4 %id)
BI760023 pooled colon, kidney, stomach .c 23 to 881 1 to 859       859/926
(92 %)
30 diff
(96.8 %id)
BI488733 brain .c 25 to 926 1 to 902       902/934
(96 %)
22 diff
(97.7 %id)
TI_45379452   .c 25 to 926 83 to 984       902/1016
(88 %)
28 diff
(97.3 %id)
BQ109214 cervical carcinoma cell line, cervix .c 26 to 659 1 to 636       636/636
(100 %)
6 diff
(99.1 %id)
BI253204 cervical carcinoma cell line, cervix .c 27 to 786 1 to 764       764/764
(100 %)
12 diff
(98.5 %id)
BE562313 Burkitt lymphoma, lymph .c 28 to 846 1 to 806       806/851
(94 %)
16 diff
(98.2 %id)
TI_59392458   .c 34 to 772 78 to 816       739/739
(100 %)
4 diff
(99.5 %id)
BM920198 pooled pancreas and spleen .c 35 to 1049 1 to 1021       1021/1028
(99 %)
20 diff
(98.1 %id)
BG824051 adenocarcinoma cell line, colon .c 36 to 787 1 to 753       753/755
(99 %)
4 diff
(99.5 %id)
BM014438 breast, mammary adenocarcinoma, cell line .c 36 to 772 1 to 737       737/737
(100 %)
4 diff
(99.5 %id)
BM460104 leiomyosarcoma, uterus .c 36 to 927 1 to 890       890/1022
(87 %)
6 diff
(99.5 %id)
BE562157 Burkitt lymphoma, lymph .c 37 to 792 35 to 851       764/868
(88 %)
46 diff
(94.8 %id)
BE560267 Burkitt lymphoma, lymph .c 46 to 792 1 to 747       747/820
(91 %)
21 diff
(97.5 %id)
BI116775 lung, small cell carcinoma .c 51 to 876 1 to 832       832/1058
(78 %)
19 diff
(98.3 %id)
DB456028 testis .c 60 to 558 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BG037086 testis .c 60 to 799 1 to 730   fully sequenced,   730/730
(100 %)
18 diff
(97.6 %id)
CA487720   .c 63 to 686 1 to 624       626/976
(64 %)
22 diff
(97.8 %id)
BG438067 large cell carcinoma, lung .c 64 to 1002 1 to 928       928/987
(94 %)
47 diff
(95.3 %id)
BM083592 large cell carcinoma, lung .c 64 to 719 1 to 652       652/668
(97 %)
13 diff
(98.1 %id)
BG489661 large cell carcinoma, lung .c 64 to 813 1 to 751       751/751
(100 %)
5 diff
(99.4 %id)
BI827720 brain, medulla .c 67 to 927 1 to 865       865/958
(90 %)
11 diff
(98.9 %id)
TI_57171974   .c 67 to 927 36 to 900       865/993
(87 %)
16 diff
(98.4 %id)
BF313150 brain, neuroblastoma .c 70 to 842 1 to 771       771/972
(79 %)
40 diff
(95.9 %id)
CA487731   .c 71 to 1069 1 to 1009       1009/1031
(97 %)
29 diff
(97.2 %id)
BE875201 large cell carcinoma, undifferentiated, lung .c 72 to 599 1 to 535       535/1019
(52 %)
18 diff
(98.3 %id)
BE909116 epithelioid carcinoma, Pancreas .c 72 to 861 1 to 788       788/884
(89 %)
22 diff
(97.6 %id)
BF346657 anaplastic oligodendroglioma with 1p/19qloss, brain .c 73 to 805 1 to 736       736/864
(85 %)
20 diff
(97.7 %id)
BE313728 brain, neuroblastoma .c 91 to 578 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BF979931 testis .c 769 to 1337 580 to 10   fully sequenced,   571/580
(98 %)
0 diff
(100 %id)
CD250296 embryonic stem cells, WA01, passage 38 .d 1 to 828 21 to 848   tiling clone,   828/850
(97 %)
15 diff
(98.3 %id)
CR601384 Neuroblastoma Cot 25-normalized .d 60 to 1697 1 to 1638 exact tiling clone,   1638/1638
(100 %)
0 diff
(100 %id)
BX394865 Neuroblastoma Cot 25-normalized .d 60 to 971 1 to 910   fully sequenced,   910/910
(100 %)
4 diff
(99.6 %id)
BX394864 Neuroblastoma Cot 25-normalized .d 910 to 1697 784 to 1   fully sequenced,   784/784
(100 %)
15 diff
(98.1 %id)
BG391561 embryonal carcinoma, cell line, testis .e 1 to 696 1 to 695   tiling clone,   695/695
(100 %)
1 diff
(99.9 %id)
BM841159 lymph node, stomach .e 200 to 698 1 to 499       499/499
(100 %)
2 diff
(99.6 %id)
BM763044 myeloma .e 200 to 698 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BM999477 Fibrosarcoma .e 414 to 1131 731 to 16   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 716/731
(97 %)
2 diff
(99.8 %id)
CX761434 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 544 to 1222 718 to 32   tiling clone, AAA   687/687
(100 %)
14 diff
(98.0 %id)
BE907874 epithelioid carcinoma, Pancreas .f 1 to 859 1 to 843   tiling clone,   843/963
(87 %)
41 diff
(95.8 %id)
BX339649 Placenta Cot 25-normalized .f 23 to 767 1 to 745   fully sequenced,   745/745
(100 %)
2 diff
(99.8 %id)
CR620912 Placenta Cot 25-normalized .f 24 to 1525 1 to 1502 exact tiling clone,   1502/1502
(100 %)
0 diff
(100 %id)
NM_001006941.2   .f 28 to 1633 1 to 1606 exact RefSeq, AAA   1606/1606
(100 %)
0 diff
(100 %id)
BQ064071 lymph, lymphoma, cell line .f 35 to 858 1 to 828       828/1074
(77 %)
6 diff
(99.5 %id)
BP216196 corpus callosum .f 49 to 630 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BI755853 brain .f 53 to 878 1 to 827       828/829
(99 %)
11 diff
(98.7 %id)
TI_57216502   .f 53 to 878 60 to 886       828/888
(93 %)
14 diff
(98.5 %id)
CD387767 embryonic trophoblasts, made from WA01 stemcells .f 63 to 854 1 to 797       797/922
(86 %)
14 diff
(98.5 %id)
AK289361   .f 72 to 1537 1 to 1466 exact     1466/1466
(100 %)
5 diff
(99.7 %id)
BP235226 coronary artery .f 72 to 653 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
BP235273 coronary artery .f 72 to 653 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
DA002304   .f 73 to 624 2 to 554   capped   553/553
(100 %)
5 diff
(99.1 %id)
BX403335 Neuroblastoma Cot 10-normalized .f 74 to 905 1 to 830       830/830
(100 %)
12 diff
(98.6 %id)
AL522934 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 75 to 920 20 to 864       845/864
(97 %)
7 diff
(99.2 %id)
BF982205 duodenal adenocarcinoma, cell line, small intestine .f 88 to 736 1 to 645       645/931
(69 %)
12 diff
(98.8 %id)
CR596636 HeLa cells Cot 25-normalized .f 90 to 1505 1 to 1416 exact     1416/1416
(100 %)
0 diff
(100 %id)
BX341744   .f 90 to 888 1 to 794   fully sequenced,   794/794
(100 %)
2 diff
(99.8 %id)
BE397791 Burkitt lymphoma, lymph .f 93 to 772 33 to 710       678/714
(94 %)
12 diff
(98.4 %id)
BE561727 Burkitt lymphoma, lymph .f 93 to 869 37 to 811       776/814
(95 %)
13 diff
(98.5 %id)
BE561968 Burkitt lymphoma, lymph .f 93 to 858 30 to 791       762/977
(77 %)
17 diff
(98.3 %id)
BI091117 cervix .f 93 to 926 1 to 832       832/946
(87 %)
14 diff
(98.6 %id)
BF313103 brain, neuroblastoma .f 102 to 853 1 to 751       751/814
(92 %)
14 diff
(98.3 %id)
BI225010 Burkitt lymphoma, lymph .f 109 to 857 1 to 746       746/775
(96 %)
3 diff
(99.7 %id)
BI225202 Burkitt lymphoma, lymph .f 111 to 1017 1 to 924       896/927
(96 %)
66 diff
(92.9 %id)
BI226899 Burkitt lymphoma, lymph .f 111 to 763 1 to 653       653/653
(100 %)
0 diff
(100 %id)
AW733065 Burkitt lymphoma, lymph .f 116 to 716 1 to 590       590/590
(100 %)
21 diff
(96.5 %id)
BQ925101 large cell carcinoma, lung .f 120 to 963 1 to 843       843/844
(99 %)
5 diff
(99.5 %id)
BE267614 Burkitt lymphoma, lymph .f 131 to 759 1 to 628       628/628
(100 %)
3 diff
(99.6 %id)
CA487780   .f 322 to 1149 1 to 833       837/1027
(81 %)
15 diff
(98.6 %id)
BE932407 head_neck .f 325 to 558 1 to 233       233/233
(100 %)
1 diff
(99.6 %id)
BQ368121 placenta_normal .f 325 to 720 37 to 432       398/432
(92 %)
6 diff
(98.7 %id)
R86657 brain .f 332 to 442 1 to 111       111/112
(99 %)
4 diff
(96.5 %id)
AI124705 brain, pooled frontal lobe .f 332 to 709 1 to 378     Submitted on the opposite strand 378/379
(99 %)
22 diff
(94.2 %id)
BP275276 Kidney .f 374 to 954 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
BF037205 adenocarcinoma, ovary .f 397 to 1019 1 to 616       616/874
(70 %)
9 diff
(99.0 %id)
BF526355 brain, glioblastoma with EGFR amplification .f 428 to 1149 8 to 721       712/807
(88 %)
22 diff
(97.3 %id)
BE732010 choriocarcinoma, placenta .f 531 to 1351 1 to 811       813/842
(96 %)
24 diff
(97.2 %id)
BU189382 melanotic melanoma, skin .f 532 to 1338 1 to 811       810/855
(94 %)
22 diff
(97.5 %id)
TI_1948128561   .f 564 to 1447 1020 to 127       892/1020
(87 %)
19 diff
(98.2 %id)
BU552851 ovary, teratocarcinoma, cell line .f 566 to 1463 1 to 899       899/899
(100 %)
13 diff
(98.6 %id)
BU553862 ovary, teratocarcinoma, cell line .f 566 to 1458 1 to 910       910/937
(97 %)
32 diff
(96.6 %id)
TI_1948128224   .f 568 to 1447 1005 to 126       880/1352
(65 %)
26 diff
(98.1 %id)
TI_1948128560   .f 568 to 1447 1000 to 125       876/1310
(66 %)
25 diff
(98.1 %id)
TI_1948128899   .f 574 to 1447 997 to 124       874/1330
(65 %)
18 diff
(98.7 %id)
BM717577 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 579 to 1091 1 to 513   fully sequenced,   513/513
(100 %)
0 diff
(100 %id)
BX400195   .f 582 to 1505 930 to 1       930/936
(99 %)
32 diff
(96.6 %id)
TI_1948128225   .f 591 to 1447 975 to 125       851/996
(85 %)
21 diff
(97.9 %id)
BP352642   .f 599 to 1181 1 to 583       583/587
(99 %)
1 diff
(99.9 %id)
BU193527 eye, retinoblastoma .f 601 to 1489 1 to 889       889/899
(98 %)
9 diff
(99.0 %id)
TI_1948129224   .f 607 to 1447 970 to 124       845/1009
(83 %)
24 diff
(97.7 %id)
BM834859 stomach .f 625 to 1051 1 to 429       429/429
(100 %)
2 diff
(99.6 %id)
BI197927 brain, neuroblastoma .f 627 to 1404 1 to 761       761/905
(84 %)
32 diff
(96.5 %id)
BI197211 brain, neuroblastoma .f 628 to 1068 1 to 450       450/689
(65 %)
14 diff
(98.0 %id)
BI197206 brain, neuroblastoma .f 628 to 1250 1 to 623       623/625
(99 %)
2 diff
(99.7 %id)
BI197920 brain, neuroblastoma .f 628 to 1471 1 to 860       858/861
(99 %)
85 diff
(90.2 %id)
BI197226 brain, neuroblastoma .f 628 to 1139 1 to 527       527/707
(74 %)
23 diff
(96.8 %id)
BI197213 brain, neuroblastoma .f 628 to 1287 1 to 674       674/820
(82 %)
30 diff
(96.4 %id)
BI199519 brain, neuroblastoma .f 628 to 1371 1 to 746       746/746
(100 %)
5 diff
(99.4 %id)
BQ332506 lung_tumor .f 636 to 1279 644 to 1       644/648
(99 %)
17 diff
(97.4 %id)
BE261322 brain, neuroblastoma .f 648 to 1339 1 to 697       696/704
(98 %)
12 diff
(98.3 %id)
BI199020 brain, neuroblastoma .f 648 to 1539 1 to 897       897/913
(98 %)
20 diff
(97.9 %id)
BI200078 brain, neuroblastoma .f 649 to 1112 1 to 465       465/465
(100 %)
4 diff
(99.2 %id)
BU180189 ductal carcinoma, cell line, Pancreas .f 649 to 1505 1 to 859       859/882
(97 %)
20 diff
(97.8 %id)
BP351836   .f 666 to 1253 1 to 590       590/590
(100 %)
7 diff
(98.9 %id)
TI_1948129223   .f 678 to 1447 890 to 122       769/1378
(55 %)
28 diff
(98.0 %id)
T81120 liver and spleen .f 693 to 982 1 to 294       294/389
(75 %)
10 diff
(97.5 %id)
BE251285 eye, retinoblastoma .f 693 to 1355 1 to 661       661/722
(91 %)
7 diff
(99.1 %id)
BX339648 Placenta Cot 25-normalized .f 706 to 1525 822 to 1   fully sequenced,   822/822
(100 %)
4 diff
(99.6 %id)
CR603692 HeLa cells Cot 25-normalized .f 710 to 1628 1 to 919       919/919
(100 %)
0 diff
(100 %id)
BX341876   .f 710 to 1572 1 to 859   fully sequenced,   859/859
(100 %)
9 diff
(99.0 %id)
BQ440410 melanotic melanoma, skin .f 710 to 1524 1 to 828   AAA   828/846
(97 %)
19 diff
(97.8 %id)
BU161837 eye, retinoblastoma .f 727 to 1496 12 to 783       772/879
(87 %)
9 diff
(99.0 %id)
BF884503 lung_tumor .f 734 to 956 26 to 248       223/248
(89 %)
6 diff
(97.6 %id)
TI_1948128900   .f 734 to 1447 839 to 125       715/1010
(70 %)
19 diff
(98.2 %id)
AL562143 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 735 to 1500 844 to 73       772/844
(91 %)
9 diff
(99.0 %id)
BF916772 uterus_tumor .f 746 to 993 248 to 1     Submitted on the opposite strand 248/248
(100 %)
0 diff
(100 %id)
BP265323 thyroid .f 746 to 1320 1 to 575       575/575
(100 %)
3 diff
(99.5 %id)
BI259077 cervical carcinoma cell line, cervix .f 755 to 1537 1 to 784   AAA   784/784
(100 %)
10 diff
(98.8 %id)
BG116024 duodenal adenocarcinoma, cell line, small intestine .f 763 to 1438 1 to 672       672/879
(76 %)
10 diff
(98.9 %id)
TI_154128236   .f 763 to 1537 842 to 76   AAA   767/960
(79 %)
13 diff
(98.7 %id)
BE070290 breast .f 769 to 1342 3 to 576       574/576
(99 %)
7 diff
(98.8 %id)
TI_159705644   .f 772 to 1536 792 to 37   AAA   756/997
(75 %)
15 diff
(98.5 %id)
BX331011   .f 789 to 1628 839 to 1       839/844
(99 %)
11 diff
(98.7 %id)
AW820540 stomach .f 790 to 1124 34 to 370       337/370
(91 %)
7 diff
(98.2 %id)
H26854 breast .f 814 to 1216 1 to 405   fully sequenced,   405/405
(100 %)
29 diff
(92.9 %id)
AA300145 uterus .f 815 to 1171 1 to 358       358/358
(100 %)
8 diff
(97.8 %id)
AW959577   .f 816 to 1332 1 to 517       517/519
(99 %)
12 diff
(97.7 %id)
BX341743   .f 827 to 1505 678 to 1   fully sequenced,   678/678
(100 %)
1 diff
(99.9 %id)
BX341875   .f 827 to 1602 776 to 1   fully sequenced,   776/776
(100 %)
2 diff
(99.8 %id)
BU539479 adenocarcinoma, cell line, breast .f 836 to 1281 1 to 447       447/1288
(34 %)
8 diff
(99.4 %id)
BG284392 adenocarcinoma, cell line, Prostate .f 837 to 1537 1 to 698   AAA   698/698
(100 %)
6 diff
(99.2 %id)
BF916293 uterus_tumor .f 841 to 1163 402 to 79     Submitted on the opposite strand 324/402
(80 %)
4 diff
(99.1 %id)
BF916298 uterus_tumor .f 841 to 1163 417 to 95     Submitted on the opposite strand 323/417
(77 %)
1 diff
(99.8 %id)
AA412630   .f 844 to 1302 1 to 460   fully sequenced,   460/460
(100 %)
1 diff
(99.8 %id)
BX118058   .f 849 to 1537 1 to 689   AAA   689/689
(100 %)
0 diff
(100 %id)
CA417370 Chondrosarcoma Cell line .f 852 to 1537 703 to 19   AAA   685/687
(99 %)
6 diff
(99.2 %id)
BU623538 cell lines, Enchondroma .f 854 to 1537 702 to 19   AAA   684/684
(100 %)
1 diff
(99.9 %id)
BE896450 melanotic melanoma, skin .f 858 to 1618 1 to 743   AAA   743/749
(99 %)
28 diff
(96.3 %id)
BG330043 eye, retinoblastoma .f 858 to 1539 1 to 679       679/801
(84 %)
9 diff
(98.9 %id)
BG329766 eye, retinoblastoma .f 858 to 1490 1 to 632       632/634
(99 %)
4 diff
(99.4 %id)
CA312760 Human Lung Epithelial cells, lung .f 864 to 1537 692 to 19   AAA   674/674
(100 %)
0 diff
(100 %id)
R23327 placenta .f 866 to 1197 1 to 338       338/339
(99 %)
10 diff
(97.1 %id)
R76440 placenta .f 866 to 1149 1 to 285       285/325
(87 %)
7 diff
(97.9 %id)
BE795053 lung, small cell carcinoma .f 874 to 1539 1 to 665       665/666
(99 %)
4 diff
(99.4 %id)
BF885296 testis_normal .f 886 to 1038 14 to 171       158/177
(89 %)
10 diff
(94.4 %id)
BP429147   .f 886 to 1216 1 to 331       331/331
(100 %)
3 diff
(99.1 %id)
AW820555 stomach .f 905 to 1146 1 to 246       246/257
(95 %)
25 diff
(90.3 %id)
BG015051 placenta_normal .f 907 to 1185 286 to 8       279/286
(97 %)
0 diff
(100 %id)
AI469225 colon, moderately-differentiated adenocarcinoma .f 921 to 1537 610 to 1       610/610
(100 %)
11 diff
(98.2 %id)
CB250595 Human Lung Epithelial cells, lung .f 934 to 1626 709 to 19   AAA   691/694
(99 %)
3 diff
(99.6 %id)
BM975188 lung .f 940 to 1630 708 to 19   AAA   690/690
(100 %)
5 diff
(99.3 %id)
AI291120 carcinoid, lung .f 951 to 1630 681 to 1   tiling clone,   681/681
(100 %)
24 diff
(96.5 %id)
AI635807 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 969 to 1537 569 to 1       569/569
(100 %)
4 diff
(99.3 %id)
AI346111 adenocarcinoma, colon .f 973 to 1539 566 to 3       564/573
(98 %)
9 diff
(98.5 %id)
BF311427 brain, neuroblastoma .f 977 to 1539 1 to 560       560/936
(59 %)
5 diff
(99.5 %id)
BI199649 brain, neuroblastoma .f 977 to 1349 1 to 376       376/659
(57 %)
8 diff
(98.8 %id)
BM674852 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1033 to 1537 523 to 19   fully sequenced, AAA   505/505
(100 %)
1 diff
(99.9 %id)
AI024860   .f 1038 to 1539 509 to 8       502/509
(98 %)
6 diff
(98.9 %id)
BM720491 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1044 to 1492 1 to 495       465/495
(93 %)
9 diff
(98.2 %id)
CB048919 Prostate .f 1062 to 1537 1 to 476   AAA   476/476
(100 %)
5 diff
(99.0 %id)
EC456291 Prostate .f 1079 to 1189 111 to 1       111/111
(100 %)
0 diff
(100 %id)
H26755 breast .f 1206 to 1528 325 to 1   fully sequenced,   325/325
(100 %)
9 diff
(97.3 %id)
R76441 placenta .f 1219 to 1523 309 to 1       309/309
(100 %)
11 diff
(96.5 %id)
AA412507   .f 1255 to 1539 291 to 7   fully sequenced,   285/291
(97 %)
0 diff
(100 %id)
R23251 placenta .f 1283 to 1539 257 to 2       256/274
(93 %)
0 diff
(100 %id)
NR_024533.1   .g 1 to 1433 1 to 1433 exact RefSeq, tiling clone, AAA   1433/1433
(100 %)
0 diff
(100 %id)
AK299575 brain .g 10 to 1461 1 to 1452 exact     1452/1452
(100 %)
1 diff
(100.0 %id)
DC374928 brain .g 10 to 577 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
TI_57236631   .g 37 to 868 26 to 853       828/885
(93 %)
28 diff
(96.9 %id)
FN152494 breast carcinoma .g 39 to 137 101 to 1     Submitted on the opposite strand 101/101
(100 %)
2 diff
(98.1 %id)
BI907913 leukocyte .g 41 to 868 1 to 824       824/856
(96 %)
27 diff
(96.9 %id)
BX340495   .g 871 to 1339 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BF939507 brain, glioblastoma (pooled) .g 885 to 1430 546 to 1       546/547
(99 %)
6 diff
(99.0 %id)
AI081403 senescent fibroblast .g 886 to 1337 464 to 13   AAA   452/452
(100 %)
0 diff
(100 %id)
AW513290 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 892 to 1339 448 to 1       448/448
(100 %)
0 diff
(100 %id)
BU540730 epithelioid carcinoma cell line, Pancreas .g 892 to 1337 1 to 446   AAA   446/446
(100 %)
0 diff
(100 %id)
AW073869 2 pooled high-grade transitional celltumors, genitourinary tract .g 893 to 1339 452 to 7       446/541
(82 %)
4 diff
(99.3 %id)
AI753650 bone marrow stroma .g 901 to 1337 455 to 18   AAA   438/438
(100 %)
1 diff
(99.8 %id)
AI597862 Prostate .g 904 to 1339 437 to 2       436/437
(99 %)
0 diff
(100 %id)
TI_151802437   .g 908 to 1431 56 to 581       526/977
(53 %)
46 diff
(95.3 %id)
BF350465 head_neck .g 910 to 1168 261 to 1       261/265
(98 %)
11 diff
(95.9 %id)
AW305210 brain, three pooled meningiomas .g 931 to 1433 505 to 3       503/511
(98 %)
15 diff
(97.1 %id)
AJ709393 heart .g 933 to 1339 1 to 407       407/413
(98 %)
5 diff
(98.8 %id)
BF002207 colon, colon tumor, RER+ .g 940 to 1430 491 to 1       491/515
(95 %)
11 diff
(97.9 %id)
BF811333 colon_ins .g 950 to 1370 1 to 424       424/424
(100 %)
9 diff
(97.9 %id)
BF447565 sympathetic trunk .g 953 to 1337 384 to 1       384/386
(99 %)
11 diff
(97.2 %id)
AI914552 colon .g 976 to 1337 364 to 1       364/364
(100 %)
30 diff
(91.8 %id)
AI248900 brain, tumor, 5 pooled (see description) .g 985 to 1339 357 to 3       355/357
(99 %)
1 diff
(99.8 %id)
AA635959 invasive tumor (cell line), Prostate .g 988 to 1403 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
AW136402   .g 1005 to 1337 350 to 18   AAA   333/333
(100 %)
1 diff
(99.7 %id)
BG152595 brain, glioblastoma without EGFR amplification .g 1015 to 1235 229 to 9       221/229
(96 %)
4 diff
(98.3 %id)
BP386490 pancreatic islet .g 1016 to 1339 1 to 331     Submitted on the opposite strand 331/335
(98 %)
10 diff
(97.1 %id)
BX337805 Placenta Cot 25-normalized .g 1050 to 1339 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
AW297350   .g 1067 to 1433 384 to 18   AAA   367/367
(100 %)
1 diff
(99.8 %id)
BE778627 eye, retinoblastoma .g 1078 to 1337 1 to 260   AAA   260/260
(100 %)
0 diff
(100 %id)
AA888293 metastatic prostate bone lesion .g 1092 to 1337 38 to 282   AAA   245/282
(86 %)
6 diff
(97.9 %id)
FN048011 breast carcinoma .g 1103 to 1183 1 to 81       81/81
(100 %)
0 diff
(100 %id)
AA552046 colon, tumor .g 1190 to 1306 117 to 1       117/117
(100 %)
0 diff
(100 %id)
CK820212 Islets of Langerhans, Pancreas .g 1269 to 1428 1 to 160       160/176
(90 %)
3 diff
(98.3 %id)
BM263153 Islets of Langerhans, Pancreas .g 1285 to 1426 1 to 142   AAA   142/142
(100 %)
2 diff
(98.6 %id)
GD146736   .g 1354 to 1430 1 to 77   AAA   77/77
(100 %)
2 diff
(97.5 %id)
CA454001   .h 1 to 819 1 to 827 E187G S188K I189Y S191V L192A ... tiling clone,   827/907
(91 %)
19 diff
(98.0 %id)
BI199873 brain, neuroblastoma .i 1 to 762 1 to 751 C147L K148Q V149G P150T P151S ... tiling clone,   751/966
(77 %)
13 diff
(98.7 %id)
BI772145 pooled lung and spleen .j 1 to 725 1 to 724 Q12R A13Q E14R G15D L16S ... tiling clone,   724/724
(100 %)
1 diff
(99.9 %id)
TI_57178912   .j 1 to 725 32 to 755 Q12R A13Q E14R G15D L16S ...     724/755
(95 %)
6 diff
(99.3 %id)
BQ072557 pooled lung and spleen .k 1 to 1003 23 to 1030 Q186X tiling clone,   1008/1039
(97 %)
45 diff
(95.7 %id)
CA488830   .k 10 to 848 1 to 838 exact     838/890
(94 %)
12 diff
(98.7 %id)
BI758720 brain .k 53 to 853 1 to 802 C180*     802/803
(99 %)
3 diff
(99.7 %id)
TI_57216438   .k 53 to 853 1 to 802 C180*     802/803
(99 %)
3 diff
(99.7 %id)
BX361405 Placenta Cot 25-normalized .k 62 to 1021 22 to 979 V114Y P115L F117S V118S F120S ... tiling clone, to resequence,   958/979
(97 %)
9 diff
(99.1 %id)
BE932437 head_neck .k 271 to 735 470 to 5       466/470
(99 %)
0 diff
(100 %id)
BG743032 skin .k 278 to 985 11 to 714   tiling clone,   704/714
(98 %)
10 diff
(98.6 %id)
FN174368 breast carcinoma .k 519 to 617 1 to 97       97/98
(98 %)
4 diff
(96.0 %id)
BX361404 Placenta Cot 25-normalized .k 1174 to 2153 972 to 6   tiling clone, to resequence,   967/980
(98 %)
16 diff
(98.4 %id)
AK297701 lung .l 1 to 910 1 to 910 exact tiling clone,   910/910
(100 %)
0 diff
(100 %id)
DC354711 lung .l 1 to 601 1 to 602 A34C P35A G36W K37Q S38E ...     602/602
(100 %)
1 diff
(99.9 %id)
DA231100 brain .m 1 to 537 2 to 538 exact tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
BF356244 head_neck .n 1 to 302 55 to 356 exact tiling clone,   302/361
(83 %)
7 diff
(98.1 %id)
BF798701 colon_ins .o 1 to 192 26 to 225   tiling clone,   200/232
(86 %)
18 diff
(92.3 %id)
T82833 liver and spleen .o 271 to 616 1 to 358   tiling clone,   358/362
(98 %)
20 diff
(94.5 %id)
AW841038 colon_normal .o 334 to 782 448 to 1 P59H     448/448
(100 %)
3 diff
(99.4 %id)
AW404502 lymph .o 462 to 912 1 to 451 exact     451/451
(100 %)
5 diff
(98.9 %id)
TI_154141443   .o 469 to 941 80 to 552 exact tiling clone,   473/474
(99 %)
1 diff
(99.8 %id)
Z20941   .p-u 1 to 196 199 to 4 E8K I21V tiling clone,   196/199
(98 %)
0 diff
(100 %id)
CR603947 Neuroblastoma Cot 25-normalized Gene ALG3, variant not shown         This clone was ignored    
BX333331 Neuroblastoma Cot 25-normalized Gene ALG3, variant not shown       fully sequenced, This clone was ignored    
BX333332 Neuroblastoma Cot 25-normalized Gene ALG3, variant not shown       fully sequenced, This clone was ignored    
AI245714 Kidney Gene ALG3, variant not shown         Suspected internal deletion, this clone was ignored    
BE547040 cervical carcinoma cell line, cervix Gene ALG3, variant not shown         This clone was ignored    
BI197372 brain, neuroblastoma Gene ALG3, variant not shown         This clone was ignored    
BI197219 brain, neuroblastoma Gene ALG3, variant not shown         This clone was ignored    
BI197935 brain, neuroblastoma Gene ALG3, variant not shown         Suspected internal deletion, this clone was ignored    
BI821493 pooled brain, lung, testis Gene ALG3, variant not shown         This clone was ignored    
TI_57200645   Gene ALG3, variant not shown         This clone was ignored    
TI_149293737   Gene ALG3, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC